A drug with the SMILES Cc1ccc(-n2c(SCC(=O)Nc3cc(S(=O)(=O)N4CCOCC4)ccc3Cl)nc3ccccc3c2=O)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 1.404\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1ccc(-n2c(SCC(=O)Nc3cc(S(=O)(=O)N4CCOCC4)ccc3Cl)nc3ccccc3c2=O)cc1
Cc1ccc(-n2c(SCC(=O)Nc3cc(S(=O)(=O)N4CCOCC4)ccc3Cl)nc3ccccc3c2=O)cc1
N-(2-chloro-5-morpholin-4-ylsulfonylphenyl)-2-[3-(4-methylphenyl)-4-oxoquinazolin-2-yl]sulfanylacetamide